Ferroptosis in Pediatric Mycoplasma pneumoniae Pneumonia: An Emerging Mechanistic Framework, Candidate Biomarkers and Their Limitations, and Translational Priorities
- 1Department of Pediatrics
Abstract
Tingting Yu, Yang Yu Department of Pediatrics, Nanjing Lishui People’s Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, People’s Republic of ChinaCorrespondence: Yang Yu, Email [email protected]: Mycoplasma pneumoniae (MP) is among the most common causes of community-acquired pneumonia in children. Against a background of widespread macrolide-resistant M. pneumoniae (MRMP) in East Asia, severe (SMPP) and refractory (RMPP) MP pneumonia have become pressing clinical problems, and a subset of children develop long-term sequelae including bronchiolitis obliterans, bronchiectasis, and organizing pneumonia. The mechanisms driving MPP severity remain incompletely understood, and tools for the early identification of high-risk children are limited. Ferroptosis—an iron-dependent form of regulated cell death driven by uncontrolled accumulation of lipid peroxides—contributes to several forms of infectious lung injury; extrapolating from this cross-pathogen evidence, we propose here that it may also participate in MP-related alveolar epithelial damage and inflammatory amplification, a hypothesis that has not previously been articulated specifically for pediatric MPP. In this narrative review of an emerging area, we summarize the molecular regulation of ferroptosis, appraise the current—and still limited—evidence linking it to pediatric MPP (explicitly separating direct MP data from cross-pathogen extrapolation), and critically evaluate the clinical applicability of ferroptosis-related biomarkers. Because direct evidence in pediatric MPP is sparse, the mechanistic model presented here is explicitly hypothesis-generating rather than a claim of established causation. We give particular attention to serum ferritin, whose pragmatic value for SMPP/RMPP risk stratification is well supported but is better understood as reflecting combined iron metabolism and systemic inflammation than as evidence of ferroptosis specifically; markedly elevated values should prompt evaluation for hemophagocytic lymphohistiocytosis/macrophage activation syndrome. We argue that ferroptosis offers a biologically plausible, complementary framework to the cytokine-storm paradigm for understanding MPP severity, and we outline priority research directions for a field that remains in its infancy.Keywords: Mycoplasma pneumoniae pneumonia, ferroptosis, children, serum ferritin, lipid peroxidation, macrolide resistance, severe pneumonia
Related
- Pstpip2-deficient mouse models in SAPHO syndrome research: Utility, mechanistic insights, and translational limitations
- The SLC7A11–ferroptosis axis in BRCA1-mutant breast cancer: current mechanistic evidence, potential therapeutic vulnerabilities, and translational perspectives
- Risk factors for plastic bronchitis complicating severe Mycoplasma pneumoniae pneumonia in children and development of a machine learning-based predictive model
- Development and validation of a nomogram for stratifying severe Mycoplasma pneumoniae pneumonia risk in children early
- Development and internal validation of a nomogram for predicting flexible bronchoscopy utilization in children with lobar pneumonia caused by Mycoplasma pneumoniae: a single-center retrospective cohort study
BibTeX
@article{yu2026ferroptosis,
title = {{Ferroptosis in Pediatric Mycoplasma pneumoniae Pneumonia: An Emerging Mechanistic Framework, Candidate Biomarkers and Their Limitations, and Translational Priorities}},
author = {Yu T and Yu Y},
journal = {Journal of Inflammation Research},
year = {2026},
month = nov,
url = {https://www.dovepress.com/ferroptosis-in-pediatric-mycoplasma-pneumoniae-pneumonia-an-emerging-m-peer-reviewed-fulltext-article-JIR},
note = {CC BY},
}
RIS
TY - JOUR
TI - Ferroptosis in Pediatric Mycoplasma pneumoniae Pneumonia: An Emerging Mechanistic Framework, Candidate Biomarkers and Their Limitations, and Translational Priorities
AU - Yu T
AU - Yu Y
PY - 2026
DA - 2026/11/15
JO - Journal of Inflammation Research
UR - https://www.dovepress.com/ferroptosis-in-pediatric-mycoplasma-pneumoniae-pneumonia-an-emerging-m-peer-reviewed-fulltext-article-JIR
AB - Tingting Yu, Yang Yu Department of Pediatrics, Nanjing Lishui People’s Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, People’s Republic of ChinaCorrespondence: Yang Yu, Email [email protected]: Mycoplasma pneumoniae (MP) is among the most common causes of community-acquired pneumonia in children. Against a background of widespread macrolide-resistant M. pneumoniae (MRMP) in East Asia, severe (SMPP) and refractory (RMPP) MP pneumonia have become pressing clinical problems, and a subset of children develop long-term sequelae including bronchiolitis obliterans, bronchiectasis, and organizing pneumonia. The mechanisms driving MPP severity remain incompletely understood, and tools for the early identification of high-risk children are limited. Ferroptosis—an iron-dependent form of regulated cell death driven by uncontrolled accumulation of lipid peroxides—contributes to several forms of infectious lung injury; extrapolating from this cross-pathogen evidence, we propose here that it may also participate in MP-related alveolar epithelial damage and inflammatory amplification, a hypothesis that has not previously been articulated specifically for pediatric MPP. In this narrative review of an emerging area, we summarize the molecular regulation of ferroptosis, appraise the current—and still limited—evidence linking it to pediatric MPP (explicitly separating direct MP data from cross-pathogen extrapolation), and critically evaluate the clinical applicability of ferroptosis-related biomarkers. Because direct evidence in pediatric MPP is sparse, the mechanistic model presented here is explicitly hypothesis-generating rather than a claim of established causation. We give particular attention to serum ferritin, whose pragmatic value for SMPP/RMPP risk stratification is well supported but is better understood as reflecting combined iron metabolism and systemic inflammation than as evidence of ferroptosis specifically; markedly elevated values should prompt evaluation for hemophagocytic lymphohistiocytosis/macrophage activation syndrome. We argue that ferroptosis offers a biologically plausible, complementary framework to the cytokine-storm paradigm for understanding MPP severity, and we outline priority research directions for a field that remains in its infancy.Keywords: Mycoplasma pneumoniae pneumonia, ferroptosis, children, serum ferritin, lipid peroxidation, macrolide resistance, severe pneumonia
SN - 1178-7031
ER -